Autoimmune disease is a condition in which the immune system is unable to recognize the body’s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well as improper functioning of body organs.
The “Autoimmune Disease Drug Industry Forecast” looks at past sales and reviews total world Autoimmune Disease Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Autoimmune Disease Drug sales for 2023 through 2029. With Autoimmune Disease Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autoimmune Disease Drug industry.
This Insight Report provides a comprehensive analysis of the global Autoimmune Disease Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autoimmune Disease Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autoimmune Disease Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autoimmune Disease Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autoimmune Disease Drug.
The global Autoimmune Disease Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Autoimmune Disease Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Autoimmune Disease Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Autoimmune Disease Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Autoimmune Disease Drug players cover Abbott Laboratories, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, AstraZeneca plc, GlaxoSmithKline, Roche and Biogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disease Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
NSAIDs
Anti-Inflammatory
Interferons
Antihyperglycemics
Others
Segmentation by application
Rheumatoid Arthritis
Type 1 Diabetes
Multiple Sclerosis
Psoriasis
Lupus
Inflammatory Bowel Disease
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
GlaxoSmithKline
Roche
Biogen
Amgen
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Autoimmune Disease Drug Market Size 2018-2029
2.1.2 Autoimmune Disease Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Autoimmune Disease Drug Segment by Type
2.2.1 NSAIDs
2.2.2 Anti-Inflammatory
2.2.3 Interferons
2.2.4 Antihyperglycemics
2.2.5 Others
2.3 Autoimmune Disease Drug Market Size by Type
2.3.1 Autoimmune Disease Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Autoimmune Disease Drug Market Size Market Share by Type (2018-2023)
2.4 Autoimmune Disease Drug Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Type 1 Diabetes
2.4.3 Multiple Sclerosis
2.4.4 Psoriasis
2.4.5 Lupus
2.4.6 Inflammatory Bowel Disease
2.4.7 Others
2.5 Autoimmune Disease Drug Market Size by Application
2.5.1 Autoimmune Disease Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Autoimmune Disease Drug Market Size Market Share by Application (2018-2023)
3 Autoimmune Disease Drug Market Size by Player
3.1 Autoimmune Disease Drug Market Size Market Share by Players
3.1.1 Global Autoimmune Disease Drug Revenue by Players (2018-2023)
3.1.2 Global Autoimmune Disease Drug Revenue Market Share by Players (2018-2023)
3.2 Global Autoimmune Disease Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Autoimmune Disease Drug by Regions
4.1 Autoimmune Disease Drug Market Size by Regions (2018-2023)
4.2 Americas Autoimmune Disease Drug Market Size Growth (2018-2023)
4.3 APAC Autoimmune Disease Drug Market Size Growth (2018-2023)
4.4 Europe Autoimmune Disease Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Autoimmune Disease Drug Market Size Growth (2018-2023)
5 Americas
5.1 Americas Autoimmune Disease Drug Market Size by Country (2018-2023)
5.2 Americas Autoimmune Disease Drug Market Size by Type (2018-2023)
5.3 Americas Autoimmune Disease Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autoimmune Disease Drug Market Size by Region (2018-2023)
6.2 APAC Autoimmune Disease Drug Market Size by Type (2018-2023)
6.3 APAC Autoimmune Disease Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Autoimmune Disease Drug by Country (2018-2023)
7.2 Europe Autoimmune Disease Drug Market Size by Type (2018-2023)
7.3 Europe Autoimmune Disease Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Autoimmune Disease Drug by Region (2018-2023)
8.2 Middle East & Africa Autoimmune Disease Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Autoimmune Disease Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Autoimmune Disease Drug Market Forecast
10.1 Global Autoimmune Disease Drug Forecast by Regions (2024-2029)
10.1.1 Global Autoimmune Disease Drug Forecast by Regions (2024-2029)
10.1.2 Americas Autoimmune Disease Drug Forecast
10.1.3 APAC Autoimmune Disease Drug Forecast
10.1.4 Europe Autoimmune Disease Drug Forecast
10.1.5 Middle East & Africa Autoimmune Disease Drug Forecast
10.2 Americas Autoimmune Disease Drug Forecast by Country (2024-2029)
10.2.1 United States Autoimmune Disease Drug Market Forecast
10.2.2 Canada Autoimmune Disease Drug Market Forecast
10.2.3 Mexico Autoimmune Disease Drug Market Forecast
10.2.4 Brazil Autoimmune Disease Drug Market Forecast
10.3 APAC Autoimmune Disease Drug Forecast by Region (2024-2029)
10.3.1 China Autoimmune Disease Drug Market Forecast
10.3.2 Japan Autoimmune Disease Drug Market Forecast
10.3.3 Korea Autoimmune Disease Drug Market Forecast
10.3.4 Southeast Asia Autoimmune Disease Drug Market Forecast
10.3.5 India Autoimmune Disease Drug Market Forecast
10.3.6 Australia Autoimmune Disease Drug Market Forecast
10.4 Europe Autoimmune Disease Drug Forecast by Country (2024-2029)
10.4.1 Germany Autoimmune Disease Drug Market Forecast
10.4.2 France Autoimmune Disease Drug Market Forecast
10.4.3 UK Autoimmune Disease Drug Market Forecast
10.4.4 Italy Autoimmune Disease Drug Market Forecast
10.4.5 Russia Autoimmune Disease Drug Market Forecast
10.5 Middle East & Africa Autoimmune Disease Drug Forecast by Region (2024-2029)
10.5.1 Egypt Autoimmune Disease Drug Market Forecast
10.5.2 South Africa Autoimmune Disease Drug Market Forecast
10.5.3 Israel Autoimmune Disease Drug Market Forecast
10.5.4 Turkey Autoimmune Disease Drug Market Forecast
10.5.5 GCC Countries Autoimmune Disease Drug Market Forecast
10.6 Global Autoimmune Disease Drug Forecast by Type (2024-2029)
10.7 Global Autoimmune Disease Drug Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Autoimmune Disease Drug Product Offered
11.1.3 Abbott Laboratories Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Autoimmune Disease Drug Product Offered
11.2.3 Pfizer Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Autoimmune Disease Drug Product Offered
11.3.3 AbbVie Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Autoimmune Disease Drug Product Offered
11.4.3 Eli Lilly Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Autoimmune Disease Drug Product Offered
11.5.3 Bristol-Myers Squibb Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 AstraZeneca plc
11.6.1 AstraZeneca plc Company Information
11.6.2 AstraZeneca plc Autoimmune Disease Drug Product Offered
11.6.3 AstraZeneca plc Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 AstraZeneca plc Main Business Overview
11.6.5 AstraZeneca plc Latest Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Information
11.7.2 GlaxoSmithKline Autoimmune Disease Drug Product Offered
11.7.3 GlaxoSmithKline Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 GlaxoSmithKline Main Business Overview
11.7.5 GlaxoSmithKline Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Autoimmune Disease Drug Product Offered
11.8.3 Roche Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Biogen
11.9.1 Biogen Company Information
11.9.2 Biogen Autoimmune Disease Drug Product Offered
11.9.3 Biogen Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Biogen Main Business Overview
11.9.5 Biogen Latest Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Autoimmune Disease Drug Product Offered
11.10.3 Amgen Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Amgen Main Business Overview
11.10.5 Amgen Latest Developments
12 Research Findings and Conclusion
*If Applicable.